184 related articles for article (PubMed ID: 22293118)
1. Using expression data for quantification of active processes in physiologically based pharmacokinetic modeling.
Meyer M; Schneckener S; Ludewig B; Kuepfer L; Lippert J
Drug Metab Dispos; 2012 May; 40(5):892-901. PubMed ID: 22293118
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data.
Jones HM; Barton HA; Lai Y; Bi YA; Kimoto E; Kempshall S; Tate SC; El-Kattan A; Houston JB; Galetin A; Fenner KS
Drug Metab Dispos; 2012 May; 40(5):1007-17. PubMed ID: 22344703
[TBL] [Abstract][Full Text] [Related]
3. Tissue-selective uptake of pravastatin in rats: contribution of a specific carrier-mediated uptake system.
Yamazaki M; Tokui T; Ishigami M; Sugiyama Y
Biopharm Drug Dispos; 1996 Dec; 17(9):775-89. PubMed ID: 8968530
[TBL] [Abstract][Full Text] [Related]
4. Physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions.
Varma MV; Lai Y; Feng B; Litchfield J; Goosen TC; Bergman A
Pharm Res; 2012 Oct; 29(10):2860-73. PubMed ID: 22638872
[TBL] [Abstract][Full Text] [Related]
5. Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition.
Poulin P; Theil FP
J Pharm Sci; 2002 May; 91(5):1358-70. PubMed ID: 11977112
[TBL] [Abstract][Full Text] [Related]
6. Prediction of the Pharmacokinetics of Pravastatin as an OATP Substrate Using Plateable Human Hepatocytes With Human Plasma Data and PBPK Modeling.
Mao J; Doshi U; Wright M; Hop CECA; Li AP; Chen Y
CPT Pharmacometrics Syst Pharmacol; 2018 Apr; 7(4):251-258. PubMed ID: 29388346
[TBL] [Abstract][Full Text] [Related]
7. Novel physiologically based pharmacokinetic modeling of patupilone for human pharmacokinetic predictions.
Xia B; Heimbach T; Lin TH; He H; Wang Y; Tan E
Cancer Chemother Pharmacol; 2012 Jun; 69(6):1567-82. PubMed ID: 22526410
[TBL] [Abstract][Full Text] [Related]
8. Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: case example nelfinavir.
Shono Y; Jantratid E; Dressman JB
Eur J Pharm Biopharm; 2011 Oct; 79(2):349-56. PubMed ID: 21527341
[TBL] [Abstract][Full Text] [Related]
9. Physiologically based pharmacokinetic modeling of cyclotrimethylenetrinitramine in male rats.
Krishnan K; Crouse LC; Bazar MA; Major MA; Reddy G
J Appl Toxicol; 2009 Oct; 29(7):629-37. PubMed ID: 19629953
[TBL] [Abstract][Full Text] [Related]
10. Physiologically based pharmacokinetic modelling of Busulfan: a new approach to describe and predict the pharmacokinetics in adults.
Diestelhorst C; Boos J; McCune JS; Russell J; Kangarloo SB; Hempel G
Cancer Chemother Pharmacol; 2013 Nov; 72(5):991-1000. PubMed ID: 24061863
[TBL] [Abstract][Full Text] [Related]
11. [Prediction of the pharmacokinetic drug-drug interaction of pravastatin and pitavastatin with cyclosporine by a digital liver model based on metabolism and transporter].
Yin XF; Lin ZQ; Yang J
Yao Xue Xue Bao; 2011 Sep; 46(9):1108-16. PubMed ID: 22121784
[TBL] [Abstract][Full Text] [Related]
12. [Transcriptomes for serial analysis of gene expression].
Marti J; Piquemal D; Manchon L; Commes T
J Soc Biol; 2002; 196(4):303-7. PubMed ID: 12645300
[TBL] [Abstract][Full Text] [Related]
13. Database for physiologically based pharmacokinetic (PBPK) modeling: physiological data for healthy and health-impaired elderly.
Thompson CM; Johns DO; Sonawane B; Barton HA; Hattis D; Tardif R; Krishnan K
J Toxicol Environ Health B Crit Rev; 2009 Jan; 12(1):1-24. PubMed ID: 19117207
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic modeling: prediction and evaluation of route dependent dosimetry of bisphenol A in monkeys with extrapolation to humans.
Fisher JW; Twaddle NC; Vanlandingham M; Doerge DR
Toxicol Appl Pharmacol; 2011 Nov; 257(1):122-36. PubMed ID: 21920375
[TBL] [Abstract][Full Text] [Related]
15. Development of a physiologically based pharmacokinetic model for bisphenol A in pregnant mice.
Kawamoto Y; Matsuyama W; Wada M; Hishikawa J; Chan MP; Nakayama A; Morisawa S
Toxicol Appl Pharmacol; 2007 Oct; 224(2):182-91. PubMed ID: 17698157
[TBL] [Abstract][Full Text] [Related]
16. Binding processes determine the stereoselective intestinal and hepatic extraction of verapamil in vivo.
Thörn HA; Sjögren E; Dickinson PA; Lennernäs H
Mol Pharm; 2012 Nov; 9(11):3034-45. PubMed ID: 23009633
[TBL] [Abstract][Full Text] [Related]
17. A physiologically based pharmacokinetic model for intravenous and ingested dimethylarsinic acid in mice.
Evans MV; Dowd SM; Kenyon EM; Hughes MF; El-Masri HA
Toxicol Sci; 2008 Aug; 104(2):250-60. PubMed ID: 18430741
[TBL] [Abstract][Full Text] [Related]
18. A spreadsheet program for modeling quantitative structure-pharmacokinetic relationships for inhaled volatile organics in humans.
Béliveau M; Krishnan K
SAR QSAR Environ Res; 2005; 16(1-2):63-77. PubMed ID: 15844443
[TBL] [Abstract][Full Text] [Related]
19. Prediction of oral pharmacokinetics of cMet kinase inhibitors in humans: physiologically based pharmacokinetic model versus traditional one-compartment model.
Yamazaki S; Skaptason J; Romero D; Vekich S; Jones HM; Tan W; Wilner KD; Koudriakova T
Drug Metab Dispos; 2011 Mar; 39(3):383-93. PubMed ID: 21098644
[TBL] [Abstract][Full Text] [Related]
20. PBPK models in risk assessment--A focus on chloroprene.
DeWoskin RS
Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
